Featured Cases

Bank of America Securities Litigation

Kaplan Fox is court appointed co-lead counsel in the case against Bank of America. The State Teachers Retirement System of Ohio, The Ohio Public Employees Retirement System, The Teacher Retirement System of Texas, Stichting Pensioenfonds Zorg en Welzijn, represented by PGGM Vermogensbeheer B.V., and Fjärde AP-Fonden are Court-appointed Co-Lead Plaintiffs...

Packaged Seafood Antitrust Litigation

Kaplan Fox has to date filed seven complaints on behalf of Affiliated Foods, Inc., Associated Grocers of New England, Inc., North Central Distributors, LLC, Cash-Wa Distributing Co. of Kearney, Inc., URM Stores, Inc., Western Family Foods, Inc., Associated Food Stores, Inc.,Giant Eagle, Inc., McLane Company, Inc., Meadowbrook Meat Company, Inc., and Associated Grocers, Inc.The  complaints allege manufacturers of packaged seafood, including  Tri-Union Seafoods, LLC, d/b/a Chicken of the Sea, King Oscar, Inc., Bumble Bee Foods, LLC f/k/a Bumble Bee Seafoods, LLC, and StarKist Co. conspired and fixed the prices of packaged seafood sold to customers in the United States from at least as early as January 1, 2003 to the present in violation of antitrust laws.

Air Cargo Shipping Services Antitrust Litigation

Kaplan Fox has been appointed by the court as co-lead counsel for direct purchasers of air cargo shipping services in an antitrust class action against the world’s major providers of air cargo shipping services.

Fannie Mae Securities Litigation

Kaplan Fox is the court-appointed co-lead counsel in the case against Federal National Mortgage Association (“Fannie Mae” or “Fannie”). The Massachusetts Pension Reserves Investment Management Board, the Boston Retirement Board, and the Tennessee Consolidated Retirement System are the court-appointed co-lead plaintiffs in this securities fraud action arising out of the financial collapse of Fannie Mae.

Neurontin Antitrust Litigation

The Plaintiffs alleged that the Defendants Pfizer Inc. and Warner-Lambert Co., illegally maintained a monopoly by preventing generic versions of its blockbuster drug, Neurontin, from coming to the market, in violation of Section 2 of the Sherman Act.